Grid eXplore Mapping Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07421076

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07421076
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07421076. Allocation not applicable; no masking; primary purpose treatment. Start 2026-04-02 (actual); primary completion 2026-11-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Grid eXplore Mapping Study
Condition
Paroxysmal Atrial Fibrillation (PAF)
Intervention (Device)
Grid X and EnSite X v3.1.1 Software
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct07421076
Content hash
312d3bd267d44d996ec2ba6b41584fd97115715028d6034a06003c91f79dd445